CUE - Cue Biopharma to Present at Two Upcoming Investor Healthcare Conferences in June 2024 | Benzinga
BOSTON, June 03, 2024 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (NASDAQ:CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and modulate disease-specific T cells, today announced that it will participate in two investor conferences this June, the Jefferies Global Healthcare Conference, to be held in New York, NY, June 4-6 and the Oppenheimer Novel Targets and Immunology Summit, to be held in New York, NY on June 24.
Cue Biopharma will discuss current clinical and preclinical progress as well as strategy in the advancement of its oncology and autoimmune platforms and biologics.
Presentation Details
Jefferies Global Healthcare ...